1-3 of 3
Julia J Scarisbrick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

Clinical Trials & Observations
Belinda A. Campbell, Gabor Dobos, Zahra Haider, H. Miles Prince, Martine Bagot, Felicity Evison, Carrie van der Weyden, Chris McCormack, Caroline Ram-Wolff, Maryam Miladi, Julia J Scarisbrick
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6639–6647.
https://doi.org/10.1182/bloodadvances.2023011041
Published: 2023
Includes: Supplemental data
Journal Articles

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

Clinical Trials & Observations
Steven M. Horwitz, Julia J. Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E. Akilov, Larisa Geskin, Jose A. Sanches, Pablo L. Ortiz-Romero, Michael Weichenthal, David C. Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, H. Miles Prince
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5098–5106.
https://doi.org/10.1182/bloodadvances.2021004710
Published: 2021
Includes: Supplemental data
Journal Articles

Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

Clinical Trials & Observations
Duncan Murray, Jack Luke McMurray, Suzy Eldershaw, Hayden Pearce, Nathaniel Davies, Julia J. Scarisbrick, Paul Moss
Journal: Blood Advances
Blood Adv (2019) 3 (4): 519–530.
https://doi.org/10.1182/bloodadvances.2018025114
Published: 2019
Includes: Supplemental data